<p>The invention relates to agents for the treatment of hepatitis C virus infection. More specifically, the invention relates to antagonists of cannabinoid type 1 receptor signalling pathway proteins and their use for the treatment of hepatitis C virus infection.</p>
申请公布号
WO2011072336(A8)
申请公布日期
2011.08.18
申请号
WO2010AU01695
申请日期
2010.12.16
申请人
THE UNIVERSITY OF SYDNEY;SYDNEY WEST AREA HEALTH SERVICE;VAN DER POORTEN, DAVID;DOUGLAS, MARK;GEORGE, JACOB
发明人
VAN DER POORTEN, DAVID;DOUGLAS, MARK;GEORGE, JACOB
